|
1
|
MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
|
J Gastroenterol
|
2005
|
3.02
|
|
2
|
CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells.
|
J Immunol
|
2004
|
1.89
|
|
3
|
Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.
|
J Immunol
|
2003
|
1.57
|
|
4
|
Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells.
|
J Immunol
|
2003
|
1.28
|
|
5
|
Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis.
|
Am J Physiol Gastrointest Liver Physiol
|
2009
|
1.27
|
|
6
|
Intestinal lamina propria retaining CD4+CD25+ regulatory T cells is a suppressive site of intestinal inflammation.
|
J Immunol
|
2007
|
1.21
|
|
7
|
MyD88-dependent pathway in T cells directly modulates the expansion of colitogenic CD4+ T cells in chronic colitis.
|
J Immunol
|
2008
|
1.12
|
|
8
|
Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.
|
Gastroenterology
|
2004
|
1.09
|
|
9
|
Extracorporeal elimination of TNF-alpha-producing CD14(dull)CD16(+) monocytes in leukocytapheresis therapy for ulcerative colitis.
|
Inflamm Bowel Dis
|
2007
|
0.95
|
|
10
|
Interleukin-18 overproduction exacerbates the development of colitis with markedly infiltrated macrophages in interleukin-18 transgenic mice.
|
J Gastroenterol Hepatol
|
2003
|
0.95
|
|
11
|
Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.
|
Gastroenterology
|
2006
|
0.93
|
|
12
|
Long-lived colitogenic CD4+ memory T cells residing outside the intestine participate in the perpetuation of chronic colitis.
|
J Immunol
|
2009
|
0.92
|
|
13
|
Ectopic CD40 ligand expression on B cells triggers intestinal inflammation.
|
J Immunol
|
2004
|
0.91
|
|
14
|
Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
|
Curr Opin Gastroenterol
|
2009
|
0.90
|
|
15
|
TH1/TH2-mediated colitis induced by adoptive transfer of CD4+CD45RBhigh T lymphocytes into nude mice.
|
Inflamm Bowel Dis
|
2006
|
0.88
|
|
16
|
IL-2 is positively involved in the development of colitogenic CD4+ IL-7R alpha high memory T cells in chronic colitis.
|
Eur J Immunol
|
2010
|
0.88
|
|
17
|
Upregulated IL-7 receptor α expression on colitogenic memory CD4+ T cells may participate in the development and persistence of chronic colitis.
|
J Immunol
|
2011
|
0.86
|
|
18
|
Colitogenic CD4+ effector-memory T cells actively recirculate in chronic colitic mice.
|
Inflamm Bowel Dis
|
2008
|
0.85
|
|
19
|
The development of colitogenic CD4(+) T cells is regulated by IL-7 in collaboration with NK cell function in a murine model of colitis.
|
J Immunol
|
2012
|
0.84
|
|
20
|
Persistent retention of colitogenic CD4+ memory T cells causes inflammatory bowel diseases to become intractable.
|
Inflamm Bowel Dis
|
2009
|
0.84
|
|
21
|
Prevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general population.
|
J Gastroenterol
|
2010
|
0.83
|
|
22
|
Systemic, but not intestinal, IL-7 is essential for the persistence of chronic colitis.
|
J Immunol
|
2008
|
0.82
|
|
23
|
Macrophage-derived IL-18 targeting for the treatment of Crohn's disease.
|
Curr Drug Targets Inflamm Allergy
|
2003
|
0.82
|
|
24
|
Role of the innate immune system in the development of chronic colitis.
|
J Gastroenterol
|
2002
|
0.81
|
|
25
|
Negative feedback regulation of colitogenic CD4+ T cells by increased granulopoiesis.
|
Inflamm Bowel Dis
|
2008
|
0.81
|
|
26
|
Hyperexpression of inducible costimulator on lamina propria mononuclear cells in rat dextran sulfate sodium colitis.
|
J Gastroenterol Hepatol
|
2004
|
0.80
|
|
27
|
ICOS costimulation in inflammatory bowel disease.
|
J Gastroenterol
|
2002
|
0.79
|
|
28
|
Continuous generation of colitogenic CD4(+) T cells in persistent colitis.
|
Eur J Immunol
|
2008
|
0.78
|
|
29
|
FTY720 suppresses the development of colitis in lymphoid-null mice by modulating the trafficking of colitogenic CD4+ T cells in bone marrow.
|
Eur J Immunol
|
2008
|
0.78
|
|
30
|
IL-7 is essential for lymphopenia-driven turnover of colitogenic CD4(+) memory T cells in chronic colitis.
|
Eur J Immunol
|
2009
|
0.77
|
|
31
|
Ameliorating effect of saporin-conjugated anti-CD11b monoclonal antibody in a murine T-cell-mediated chronic colitis.
|
J Gastroenterol Hepatol
|
2006
|
0.76
|